Table 3.
Author | Exosome origin | Tumor model | Outcomes | Mechanisms |
---|---|---|---|---|
Li, Hongdan et al. [34] | Human bone marrow MSCs from patients undergoing hip-replacement surgery | Colon cancer cells (HCT-116, HT-29, and SW-480) | Increased the population of colon cancer stem cells | miR-142-3p in exosomes promoted the Notch signaling pathways by downregulating Numb |
| ||||
Zhang, Yanling et al. [35] | Human omental adipose-derived MSCs from cancer-free female donors | Human EOC cell lines (SKOV3, A2780, and HO-8910) | Promoted cancer progression | Affect proteomic profile of tumor cells via paracrine mechanism |
| ||||
Roccaro AM et al. [36] | Human bone marrow MSCs from normal or cancer patients | Multiple myeloma (MM) cells | MM BM-MSCs–derived exosomes promoted MM tumor growth, normal BM-MSC exosomes inhibited the growth of MM cells | Impact MM cell adhesion |
| ||||
Makiko Ono et al. [37] | Human bone marrow MSCs | BM2 cells | Slowed tumor growth | Exosomal transfer of miR-23b and its suppression of MARCKS |
| ||||
Reza AM et al. [38] | Human adipose MSCs | A2780 and SKOV-3 ovarian cancer cells | Inhibited proliferation of ovarian cancer cells | Upregulates proapoptotic molecules |